Blue Water Vaccines is a biotechnology business based in the US. Blue Water Vaccines shares (BWV) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.17 – the same closing value as a week prior. Blue Water Vaccines employs 12 staff and has a market cap (total outstanding shares value) of 0.00.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.17 |
|---|---|
| 52-week range | $0.15 - $0.50 |
| 50-day moving average | $0.28 |
| 200-day moving average | $0.74 |
| Wall St. target price | $9.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-1.08 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.166 from 2024-02-22
| 1 week (2024-09-30) | N/A |
|---|---|
| 1 month (2024-09-07) | N/A |
| 3 months (2024-07-07) | N/A |
| 6 months (2024-04-07) | N/A |
| 1 year (2023-10-11) | -62.27% |
|---|---|
| 2 years (2022-10-11) | -89.56% |
| 3 years (2021-10-07) | N/A |
| 5 years (2019-10-07) | N/A |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -30.22% |
| Return on equity TTM | -101.63% |
| Profit margin | 0% |
| Book value | $0.57 |
| Market Capitalization | $3.4 million |
TTM: trailing 12 months
Blue Water Biotech, Inc. , a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company owns ENTADFI, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia. It is also developing a streptococcus pneumoniae vaccine candidate, which is designed to prevent infectious middle ear infections in children, and prevention of pneumonia in the elderly; and universal flu vaccine that provide protection from all virulent strains in addition to licensing a novel norovirus S&P nanoparticle versatile virus-like particle vaccine platform from Cincinnati Children's to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, and others. The company was formerly known as Blue Water Vaccines, Inc. and changed its name to Blue Water Biotech, Inc. in April 2023.
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
These are the stocks to buy when you don’t have much to spend.
Explore the best bonuses for opening a new brokerage account.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out the best-performing ETFs so far in 2024.
Read our beginner’s guide to trading options in the US.